These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 20816581)
1. Heritability of hematologic malignancies: from pedigrees to genomics. Churpek JE; Onel K Hematol Oncol Clin North Am; 2010 Oct; 24(5):939-72. PubMed ID: 20816581 [TBL] [Abstract][Full Text] [Related]
2. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis. Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295 [TBL] [Abstract][Full Text] [Related]
4. Discussing and managing hematologic germ line variants. Kohlmann W; Schiffman JD Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496 [TBL] [Abstract][Full Text] [Related]
5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels. DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723 [TBL] [Abstract][Full Text] [Related]
6. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers. Mangaonkar AA; Patnaik MM Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604 [TBL] [Abstract][Full Text] [Related]
7. Leveraging cancer genome information in hematologic malignancies. Rampal R; Levine RL J Clin Oncol; 2013 May; 31(15):1885-92. PubMed ID: 23589554 [TBL] [Abstract][Full Text] [Related]
8. Predisposition to pediatric and hematologic cancers: a moving target. Malkin D; Nichols KE; Zelley K; Schiffman JD Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136 [TBL] [Abstract][Full Text] [Related]
9. Genomic testing in myeloid malignancy. Docking TR; Karsan A Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982 [TBL] [Abstract][Full Text] [Related]
10. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities. Trottier AM; Godley LA Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436 [TBL] [Abstract][Full Text] [Related]
11. Hereditary myeloid malignancies. Rafei H; DiNardo CD Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998 [TBL] [Abstract][Full Text] [Related]
12. Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes. Ansar S; Malcolmson J; Farncombe KM; Yee K; Kim RH; Sibai H Genet Med; 2022 Nov; 24(11):2367-2379. PubMed ID: 36112138 [TBL] [Abstract][Full Text] [Related]